KCNMA1 Expression Is Downregulated in Colorectal Cancer via Epigenetic Mechanisms
Maria Sofia Basile(University of Catania), Antonio Pesce(University of Catania), Lucia Salvatorelli(University of Catania), Paolo Fagone(University of Catania), Santa Mammana(University of Catania), Katia Mangano(University of Catania), G. La Greca(University of Catania), Stefano Puleo(Istituto di Studi sul Mediterraneo (CNR - ISMed)), Gaetano Magro(University of Catania), Ferdinando Nicoletti(University of Catania), Giovanni Li Destri(University of Catania)
Cited by 29
Related Papers
Natural products in drug discovery: advances and opportunities
|Nature Reviews Drug Discovery|2021|5.2k
Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR Inhibitors: Rationale and Importance to Inhibiting These Pathways in Human Health
|Oncotarget|2011|579
GSK-3 as potential target for therapeutic intervention in cancer
|Oncotarget|2014|508
The neuropathic pain: An overview of the current treatment and future therapeutic approaches
|International Journal of Immunopathology and Pharmacology|2019|495